adult obesity rate declined to 37 percent, down from 39.9 percent in 2022
These results closely mirrored clinical findings, which show that individuals with PCOS and obesity typically lose around 16.7 pounds after three months and 25.3 pounds after six months on low-dose Semaglutide
A qualified prescriber reviews your health information to decide whether treatment is suitable and safe
Technique: Inject under the skin in the abdomen, thigh, or upper arm
Policy The findings support continuing the use of GLP-1 medications in women with metabolic risk factors who are considering pregnancy, says Cara Dolin, MD, a maternal-fetal medicine specialist, and a coauthor of the research, which was presented at the Society of Maternal-Fetal Medicine pregnancy meeting in February 2026